Corpus Intelligence IC Memo — BAPTIST MEDICAL CENTER - ATTALA 2026-04-26 11:18 UTC
IC Memo — BAPTIST MEDICAL CENTER - ATTALA
Investment Committee Memorandum | MS | 25 beds | Grade D | EBITDA uplift $1.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BAPTIST MEDICAL CENTER - ATTALA

CCN 251336 | ATTALA, MS | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BAPTIST MEDICAL CENTER - ATTALA is a 25-bed rural/critical access in ATTALA, MS with $15.8M in net patient revenue and a -14.9% operating margin. The hospital serves a payer mix of 69.8% Medicare, 1.6% Medicaid, and 28.5% commercial.

Thesis: Turnaround. Our ML models identify $1.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -14.9% to -7.5% (+736bps).

Net Revenue HCRIS$15.8M
Current EBITDA COMPUTED$-2.4M
Operating Margin COMPUTED-14.9%
Occupancy HCRIS38.7%
Revenue / Bed COMPUTED$634K
Net-to-Gross HCRIS40.7%
Distress Probability ML53.7%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
69
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of -14.9% places it below the state median. Among 69 size-comparable peers (12-50 beds), the median margin is -14.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 69 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BAPTIST MEDICAL CENTER - ATTAL (Target)MS25$15.8M-14.9%
KINGS DAUGHTERS MEDICAL CENTERMS22$91.5M-8.4%
NORTH SUNFLOWER COUNTY HOSPITAMS25$70.1M-7.2%
MISSISSIPPI METHODIST REHAB CEMS31$68.1M-0.5%
UMMC-GRENADAMS49$63.7M7.1%
NESHOBA COUNTY GENERAL HOSPITAMS38$47.6M-19.7%
MONROE REGIONAL HOSPITALMS25$45.6M0.9%
CLAY COUNTY MEDICAL CORPORATIOMS49$45.4M0.5%
HIGHLAND COMMUNITY HOSPITALMS49$42.4M-27.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$333K+210bp18mo
Cost to Collect4.5%2.5%$317K+200bp12mo
Denial Rate Reduction12.0%6.5%$314K+198bp12mo
A/R Days Reduction5200.0%3800.0%$193K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$333K
Cost to Collect
$317K
Denial Rate Reduction
$314K
A/R Days Reduction
$193K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.2M
Current EBITDA$-2.4M
+ RCM Uplift+$1.2M
Pro Forma EBITDA$-1.2M
Current Margin-14.9%
Pro Forma Margin-7.5%
WC Released (1x)$608K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.6M$-3.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.6M$-5.5M0.00x-100.0%
Bull Case9.0x11.0x$-3.3M$-2.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.3M$-4.0M0.00x-100.0%
Bear Case11.0x10.0x$-4.0M$-8.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.0M$-10.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 69.8% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
HighElevated distress probabilityModel estimates 53.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 69 hospitals with 12-50 beds
  • Same-state prioritization (n=70)
  • Comp margins: P25=-25.8% / P50=-14.9% / P75=-5.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.